Forearm Knee Joint Tibia Waist Lower back Knee Joint FIGURE 1. Location of transcutaneous electrical nerve stimulation electrodes at each body site.
Introduction: Strong nonpainful transcutaneous electrical nerve stimulation (TENS) is prerequisite to a successful analgesic outcome although the ease with which this sensation is achieved is likely to depend on the magnitude of current amplitude (mA) between sensory detection threshold (SDT) and pain threshold, that is, the current window.
Objectives: To measure the current window and participant's perception of the comfort of the TENS sensation at different body sites.
Methods: A repeated measure cross-over study was conducted using 30 healthy adult volunteers. Current amplitudes (mA) of TENS [2 pulses per second (pps); 30 pps; 80 pps] at SDT, pain threshold, and strong nonpainful intensities were measured at the tibia (bone), knee joint (connective tissue), lower back [paraspinal (skeletal) muscle], volar surface of forearm (nerve) and waist (fat). The amplitude to achieve a strong nonpainful intensity was represented as a percentage of the current window. Data were analyzed using repeated measures analysis of variance.
Results: Effects were detected for body site and frequency for SDT (P < 0.001, P = 0.018, respectively), current window (P < 0.001, P < 0.001, respectively), and strong nonpainful TENS as a percentage of the current window (P = 0.002, P < 0.001, respectively). The current window was larger for the knee joint compared with tibia (difference [95% confidence interval] = 12.76 mA [4.25, 21.28] ; P = 0.001) and forearm (10.33 mA [2.62, 18 .40]; P = 0.006), and for the lower back compared with tibia (12.10 mA [1.65, 22 .52]; P = 0.015) and forearm (9.65 mA [1.06, 18.24] ; P = 0.019). The current window was larger for 2 pps compared with 30 pps (P < 0.001) and 80 pps (P < 0.001). Participants rated strong nonpainful TENS as most comfortable at the lower back (P < 0.001) and least comfortable at the tibia and forearm (P < 0.001).
Conclusions: TENS is most comfortable and easiest to titrate to a strong nonpainful intensity when applied over areas of muscle and soft tissue. T ranscutaneous electrical nerve stimulation (TENS) is a noninvasive, inexpensive, and self-administered analgesic technique. 1, 2 In clinical practice TENS is administered to selectively activate low-threshold peripheral afferent nerves by titrating intensity to produce a strong yet nonpainful TENS sensation at the site of pain (ie, conventional TENS). A meta-analysis of 21 randomized controlled trials demonstrated superiority of strong nonpainful TENS administered at the site of postoperative pain compared with TENS administered at insufficient intensities away from the pain. 3 Strong nonpainful TENS raises pain threshold (PTh) to a greater extent compared with sensory threshold TENS or no current control for experimentally induced mechanical stimuli 4-6 and CO 2 laser stimuli. 7 Animal studies demonstrate that TENS needs to be delivered in the receptive field to reduce ongoing transmission of central nociceptive neurons 2, 8 and human studies show that TENS at ipsilateral sites is superior to TENS at contralateral sites. 5, 9 In clinical practice TENS produces pain relief for some patients and not for others, and this has led to uncertainty about efficacy and effectiveness. 9 Inadequate pain relief during TENS may be due to difficulty in titrating current amplitude to achieve a strong nonpainful TENS sensation. This depends on the range of the current (mA) between sensory detection threshold (SDT; the point at which a user perceives the first sensation of TENS) and PTh (the point at which a user perceives TENS to be painful), that is, the therapeutic current window. The precision of titrating current amplitude to a strong nonpainful level will be reduced if the current window is small. Studies using quantitative sensory testing procedures have demonstrated that sensitivity and discriminative ability toward different stimuli vary according to body site. [10] [11] [12] There has been much research on the effect of TENS frequency, pattern, width, and waveform using healthy humans exposed to experimentally induced pain. [13] [14] [15] Appropriate electrode placement is also necessary to maximize TENS effects; however, studies that investigate electrode placement are few and tend to find no difference in pain outcome between sites. [16] [17] [18] Recently, Moran et al 6 measured pressure pain threshold in healthy human volunteers receiving TENS at strong nonpainful (mean ± SD = 39.13 ± 1.27 mA), sensory threshold (22.46 ± 0.84 mA), and below sensory threshold (11.49 ± 0.74 mA) intensities. They found a positive correlation between hypoalgesia and current amplitude of TENS and concluded that there was a dose-response effect of TENS with larger effects occurring at higher amplitudes. To our knowledge, there have been no investigations on the effect of electrode placement on the size of the current window and perceived comfort of TENS sensation.
We hypothesized that the magnitude of the current window and comfort of TENS sensation varied according to body site. To investigate this, we measured the current window for 3 frequencies of TENS at 5 body sites in healthy pain-free human participants.
MATERIALS AND METHODS
A repeated measures design was used in which all participants received 3 frequencies of TENS at 5 body sites in a randomized order. The study was approved by the Research Ethics Sub-Committee of Leeds Metropolitan University.
Participants, Recruitment, and Selection
Healthy volunteers were recruited from staff and students of Leeds Metropolitan University. Volunteers expressing interest in the study were provided with a participant information sheet and given at least 48 hours to decide whether they wished to participate. Each participant took part in 1 experiment facilitated by the principal investigator (N.H.). Before the experiment, volunteers were screened against the following eligibility criteria: healthy pain-free adult aged 18 years or above, not taking medication in the previous week, no previous use of TENS, and not contraindicated to TENS according to the Chartered Society for Physiotherapy (UK) guidelines for safe use of electrophysical agents. 19 Contraindications to TENS for this study were having a pacemaker in situ and being pregnant. As successful TENS depends on normally functioning nerves, skin sensation was tested at each body site before applying TENS using a simple sharp-blunt test (pinprick and brush, respectively).
Participants were informed that there was a risk of minor side effects from the TENS including skin irritation, dizziness, and nausea and that they could withdraw from the experiment at any point and without reason. Written consent was obtained from all participants.
Procedure
Experiments were carried out in a quiet laboratory with participants sitting or lying on a plinth as required. Body sites were chosen to reflect a predominance of different types of tissue beneath the skin, which included the following: tibia (bone); knee joint (connective tissue); lower back [paraspinal (skeletal) muscle]; volar surface of forearm (nerve) and waist (fat) ( Fig. 1 ). Measurements of current amplitude (mA) were taken for SDT, PTh, and strong nonpainful sensation during TENS delivered at 2 pulses per second (pps), 30 pps, and 80 pps at each body site. Frequencies were chosen to reflect those commonly used in research and clinical practice for low-frequency, highfrequency, and medium-frequency TENS. 1, 2 Each participant's age, sex, height, and weight were collected and body mass index (BMI) was calculated before the start of the experiment. Data for current amplitude (mA) were collected in a series of "measurement runs." Each measurement run used an identical procedure whereby the principal investigator (N.H.) increased the current amplitude of TENS until the participant reported SDT followed by PTh after which the amplitude was reduced until the participant reported a strong nonpainful sensation. Three measurement runs (1 run for each frequency) were taken before moving on to the next body site. All measurements were completed in the single experimental session. A computerized random number generator randomized the order of frequencies at each site and the order of the body sites.
Two self-adhering TENS electrodes (50Â 50 mm 2 electrodes, ACUPAD woven stainless steel cloth electrodes with Multistick adhesive gel, Nidd Valley Medical Ltd, Harrogate, UK) were applied to the skin at each body site with a leading edge separation of 50 mm. TENS was administered using a constant current Pro-TENS device (Nidd Valley Medical Ltd) delivering a biphasic pulse waveform with a 200 ms pulse duration and a continuous pulse pattern (mode). A Type 4000 Frye Analyser (RDG Medical Ltd, Croydon, UK) was used to measure current amplitude, peak-to-peak voltage, pulse duration, pulse frequency, and skin impedance during TENS.
During each measurement run participants were instructed to remain still, look straight ahead, and concentrate on the sensations experienced. The investigator increased the current amplitude of TENS by turning the "intensity dial" at a rate of 0.5 mA/s. Participants were instructed to say "Detect" when they perceived the first sensation of TENS (taken as SDT) and "Pain" at the point when they first perceived the sensation of TENS to be painful (taken as PTh). The investigator continued to increase the current amplitude 2 mA above "Pain" before decreasing the current amplitude at the same rate (0.5 mA/s) until the participant perceived the sensation as strong but comfortable, which they reported as "Strong." It was decided not to use a method of ascending limits (ie, a measurement order of sensory detection threshold, strong nonpainful, and pain threshold), because pilot work suggested that individuals underestimated the amplitude required to achieve a strong nonpainful TENS if they had not previously experienced the current amplitude necessary to achieve PTh. Moreover, in clinical practice it is common to allow patients to experience the scale end points before they can determine what is strong but comfortable. The investigator recorded the current amplitude corresponding to the first signs of visible muscle contraction (taken as motor detection threshold) if it occurred at any point during the measurement run. Before the experiment participants were informed that visible muscle contractions may occur during TENS administration, that they are normal, and that unless perceived as unacceptable the investigator would continue to increase the current amplitude.
Current amplitude was held at the strong nonpainful level for 1 minute, and the participant asked to rate "How comfortable do you find the TENS sensation at this body site?" on a 100-mm visual analog scale anchored at each end with the terms "very comfortable" (0 mm) and "very uncomfortable" (100 mm). Once a measurement run had been completed, participants shaded a body diagram to identify the distribution of the TENS sensation. On completion of the measurement runs for the 3 frequencies at a particular body site the participant was asked to rate whether they preferred "slow" (2 pps), "medium" (30 pps), or "fast" (80 pps) TENS. At the end of the experiment, participants were asked to identify the body site at which TENS was most and least comfortable.
Data Analysis
A sample size of 30 participants was chosen in line with recommendations to estimate parameters in feasibility studies. 20, 21 The current window for each TENS frequency and body site was calculated for each participant by subtracting the current amplitude for SDT from PTh. The current amplitude necessary to achieve a strong nonpainful intensity was represented as a percentage of the current window and was calculated by subtracting SDT (mA) from the strong nonpainful level (mA) and dividing by the current window (mA). We used strong nonpainful TENS as a percentage because standardizing current window across the cohort made for easier descriptive comparisons between participants. Nevertheless, the use of percentage values may regress to the mean; therefore we also conducted a repeated measures analysis of variance (RM ANOVA) on current amplitude necessary to achieve a strong nonpainful intensity relative to SDT.
Data were normally distributed and a within-participant 3 Â5 factorial RM ANOVA was performed on current amplitude data. Factors were frequency (3 levels: 2 pps, 30 pps, and 80 pps) and site 5 levels: tibia (bone), knee joint (connective tissue), lower back [paraspinal (skeletal) muscle], volar surface of forearm (nerve) and waist (fat). Pairwise comparisons were used to isolate differences with a set at 0.05, b at 0.2, and adjustment made for multiple comparisons using the Bonferroni correction. Greenhouse-Geisser corrections were used when the Mauchly test of sphericity was not assumed. The distributions of ratings for preferred frequencies and body site were analyzed using w 2 tests. A visual inspection of the location of TENS sensations for each frequency at each site were created by overlaying the body chart of each participant. Statistical analyses were performed using SPSS version 17.
RESULTS

Characteristics of the Study Group
Thirty volunteers approached the research team and expressed interest in the study (Fig. 2 ). All were enrolled into and subsequently completed the study [mean (range) age = 27.03 (19 to 53) y; 17 females; mean (range) BMI = 24.05 (18.5 to 33.3) kg/m 2 ].
Mean (SD) current amplitude (mA) for SDT, PTh, and strong nonpainful TENS across the pulse frequencies and body sites are presented in Table 1 . RM ANOVA on SDT found effects for site (F = 30.15, P < 0.001) and for frequency (F = 5.31, P = 0.018) and for siteÂ frequency interaction (F = 2.86, P = 0.021). Pairwise comparisons found that SDTs were higher for the tibia when compared with lower back ( .60]; P < 0.001). Pairwise comparisons found that SDTs were lower for 80 pps when compared with 2 pps (P = 0.033) and 30 pps (P = 0.029), but there were no differences between 2 and 30 pps (P = 0.396). RM ANOVA on the current window for TENS (ie, PTh relative to SDT) found effects for site (F = 8.67, P < 0.001) and for frequency (F = 65.31, P < 0.001) and for siteÂ frequency interaction (F = 3.28, P = 0.009, Fig. 3 ). Pairwise comparisons found that the current window for TENS was larger for knee joint compared with tibia (mean difference [95% CI] = 12.76 mA [4.25, 21.28] ; P = 0.001) and forearm (10.33 mA [2.62, 18.40]; P = 0.006), and larger for lower back compared with tibia (12.10 mA [1.65, 22.52]; P = 0.015) and forearm (9.65 mA [1.06, 18.24]; P = 0.019). While receiving TENS over the forearm, some participants stated that although not painful they did not want TENS to be increased any further as they found the muscle contractions unacceptable. This may have resulted in the smaller current window for forearm. Pairwise comparisons found that the current window was higher for 2 pps compared with 30 pps (P < 0.001) and 80 pps (P < 0.001), but there were no differences between 30 pps and 80 pps (P = 1.00).
When BMI was introduced as a covariate into the model for current window (ie, PTh ÀSDT) effects for frequency remained (F = 4.41, P = 0.029), but effects for site (F = 0.724, P = 0.561) and frequency Âsite interaction disappeared (F = 1.48, P = 0.204). There were no effects of other interactions (frequency ÂBMI: F = 1.23, P = 0.293; site ÂBMI: F = 0.832, P = 0.496; frequency Âsite ÂBMI: F = 1.13, P = 0.349). Thus, there was a significant effect of frequency on the size of the current window after controlling for the effect of BMI but there was not a significant effect of site after controlling for the effect of BMI. Mean (SD) current amplitude (mA) for strong nonpainful TENS as a percentage of the current window is presented in Table 2 . RM ANOVA detected effects for frequency (F = 10.315, P < 0.001) and site (F = 5.90, P = 0.002) and found no effects for siteÂ frequency interaction (F = 1.03, P = 0.393). Pairwise comparisons found that strong nonpainful TENS relative to the current window was lower for forearm compared with knee joint (mean difference [95% CI] = À 13.93 mA [À26.81, À1.06]; P = 0.027) and waist (À 12.57 mA [À25.06, À0.076]; P = 0.048). Pairwise comparisons found that strong nonpainful TENS relative to the current window was higher for 2 pps compared with 30 pps (P = 0.001) and 80 pps (P = 0.004), but there were no differences between 30 pps and 80 pps (P = 1.00). RM ANOVA on current amplitude necessary to achieve a strong nonpainful intensity corrected for SDT produced similar findings [frequency (F = 53.33, P < 0.001), site (F = 10.03, P < 0.001), and siteÂ frequency interaction (F = 3.58, P = 0.01)].
When BMI was introduced as a covariate into the model for strong nonpainful effects corrected for SDT, effects for frequency remained (F = 5.124, P = 0.023) but effects for site (F = 0.993, P = 0.404) and frequencyÂsite interaction disappeared (F = 2.149, P = 0.085). There were no effects of other interactions (frequencyÂBMI: F = 1.382, P = 0.255; siteÂ BMI: F = 0.970), P = 0.415; frequencyÂsiteÂBMI: F = 1.667, P = 0.167). Thus, there was a significant effect of frequency on strong nonpainful TENS relative to sensory detection (ie, the current window) after controlling for the effect of BMI, but there was not a significant effect of site after controlling for the effect of BMI.
At the end of the experiment a larger proportion of participants rated strong nonpainful TENS, irrespective of frequency, to be most comfortable at the lower back (P < 0.001) and least comfortable at the tibia and forearm (P < 0.001; Table 3 ). RM ANOVA on visual analog scale ratings of "How comfortable do you find the TENS sensation at this body site?" detected significant effects for site (F = 3.220, P = 0.025) and frequency (F = 3.478, P = 0.051) but not for frequencyÂsite interaction (F = 1.868, P = 0.103). Participants rated TENS at the forearm as less comfortable than the lower back (mean [95% CI] difference = 8.63 mm [0.13, 17.13 mm]; P = 0.044) and the waist (mean [95% CI] difference = 5.96 mm [À0.39, 12.31 mm]; P = 0.079), although this just failed to reach statistical significance. Effects were detected across sites for 30 pps and 80 pps but not for 2 pps ( 30, 21. 62 mm]; P = 0.063). The magnitude of statistically significant differences was small.
Pairwise comparisons failed to detect differences in comfort across the frequencies, although a larger proportion of participants rated 80 pps as their preferred frequency for strong nonpainful TENS at the knee joint and lower back ( Table 5 ). There was tentative evidence that fewer participants preferred 30 pps at the forearm (P = 0.083). There were no significant differences in preferred frequencies at the tibia and waist.
Visual inspection of the body charts revealed that the largest area of coverage of TENS sensation was at the forearm with TENS sensation projecting into the hand and fingers and following the distribution of the median nerve. The smallest area of coverage was the lower back and knee joint. Similar distributions of TENS sensation were observed for each of the 3 frequencies. At the end of the experiment, some participants revealed that they found it easier to determine the distribution of TENS sensation at 30 and 80 pps because of the higher rate of delivery of the electrical pulses.
DISCUSSION
This study found that the size of the current window for TENS intensity, measured as PTh relative to SDT, depended on the site of stimulation and on TENS frequency, although these appeared to be independent of each other. Larger current windows were found for the lower back (skeletal muscle) and the knee joint (connective tissue) when compared with the tibia (bone) and forearm (nerve). The current window for TENS at 2 pps was larger than that at 30 pps or 80 pps. A larger proportion of participants rated 80 pps as their preferred frequency at the knee joint and lower back, although there were no differences in preferences at the tibia and waist. For most sites, a strong nonpainful TENS intensity was achieved using current amplitudes that were about 80% of PTh.
Our study is the first to map the size of the current window for different TENS frequencies at different body sites. Sites were chosen to reflect various body locations and a predominance of different types of tissue beneath the skin. TENS was least comfortable when applied on skin overlying bone (tibia) and most comfortable when applied over skeletal muscle (lower back) or connective tissue (knee joint). This is consistent with clinical experience and advice from opinion leaders that TENS is most comfortable when applied over areas of muscle and soft tissue. 2, 22 Two factors are likely to influence the sensation of TENS at different body sites. These are the different types of tissue beneath the TENS electrodes at different body sites and the sensitivity of such tissue types to stimuli applied to the skin surface. SDT, which occurs at lower current amplitudes, is likely to reflect the density of lowthreshold, large diameter fibers beneath the TENS electrodes, and we found most sensitive areas to be the forearm, waist, and lower back when compared with the tibia and knee joint. Normative data using quantitative sensory testing find somatotopy consistent with the somatosensory homunculus with lower detection and PThs for more sen-sitive body sites. 23, 24 Likewise, temporal discrimination thresholds for pairs of electrical stimuli are related to the somatosensory homunculus. 25 Davey et al 11 found that sensory detection (perceptual) thresholds to cutaneous electrical stimuli delivered at 3 pps tended to follow known somatotopy although they failed to detect a correlation between 2-point discriminative ability and SDT. SDT is dependent on skin thickness and, unlike 2-point discrimination, is less likely to be affected by central processes such as lateral inhibition. Sang et al 26 have shown that SDT results from recruitment of A-b fibers while PTh involves recruitment of A-d fibers, with PTh not being achieved by a current less than twice the SDT. It seems likely that histologic variation of vessels and nerves in different body sites is responsible for the differences in sensory and pain detection thresholds at different body sites during electrical stimulation and ultimately the size of the current window. Interestingly, Sang et al 26 found that estimates of sensory detection and PTh using electrical stimuli were affected by location of nerves close to the electrodes but not affected by alterations in the electrical microenvironment of the stimulation site, such as galvanic skin response and habituation or sensitization resulting from the repetitive delivery of electrical pulsed currents.
We found evidence that BMI was a possible confounder in our findings for site but not for frequency suggesting that the relationship between site and current window is not independent of BMI. We speculate that site may be important in individuals with low body fat because in sites of no underlying fat or muscle, the window was narrow. The association may disappear in individuals with high body fat because of larger amounts of underlying tissue. To our knowledge, there has been no research on the effect of BMI or body fat on response to TENS, and this would be an area worthy of further study.
As the amplitude of TENS increases current will penetrate and stimulate deeper tissue. 22 Thus, the size of the current window will depend on the sensitivity of skin and the sensitivity of deeper tissue to electrical stimuli and whether the activation of the relevant nerves produces a perceptual experience. There is somatotopic organization of the insula with respect to pain arising from cutaneous and muscle tissue. 27 We found smaller current windows for the tibia (bone) and forearm (nerve) when compared with lower back (skeletal muscle) and the knee joint (connective tissue). Moreover, TENS over bone and forearm were also found to be least comfortable. This small current window for TENS makes it difficult for patients to precisely titrate current to achieve a strong nonpainful TENS intensity. For most sites, a strong nonpainful TENS intensity was achieved using current amplitudes that were approximately 80% of PTh. Although the amplitude necessary to achieve a strong nonpainful TENS intensity relative to PTh is constant, titration is easier and more precise if the current window is large. Accidentally increasing amplitude too far may result in TENS-induced pain, which may deter further TENS use and reduce compliance. This may be a barrier to effective TENS use in patients with comorbidities influencing dexterity such as rheumatoid arthritis.
Our findings suggest that TENS should be positioned over soft tissue and in proximal sites in the first instance and that TENS may be more beneficial for conditions affecting pain in these areas. A meta-analysis of randomized controlled clinical trials on TENS found that TENS was effective for musculoskeletal pain. 28 Animal studies have also found that hypoalgesia during TENS was greater when deeper muscular tissue was stimulated. [29] [30] [31] The largest area of coverage of TENS sensation occurred at the forearm with sensation projecting into the fingers and hand due to direct stimulation of the median nerve. Often patients are adviced to apply TENS over peripheral nerves to generate a stronger afferent input leading to stronger inhibition of central nociceptive transmission cells. 22 TENS of peripheral nerves can also be used to "project TENS sensation to distal sites such as the hand and foot, which can be particularly useful for phantom limb pain." 32 Interestingly, TENS over the median nerve of the forearm resulted in TENS-induced contractions of the hand and fingers. These contractions were not painful, but some of our TENS naive participants found them unacceptable and rated TENS as uncomfortable at this site, with lower current amplitude relative to PTh recorded. With experience TENS users are able to tolerate finger twitching when TENS is used to relieve the symptoms of Raynaud syndrome, 33 and are able to tolerate TENS-induced muscle twitching in other body sites during acupuncture-like TENS. 1, 22 Interestingly, we found that the smallest area of coverage of TENS sensation was the lower back and knee joint possibly because TENS was not delivered over a large peripheral nerve. Clinical experience suggests that applying TENS over a nerve leading to a large muscle mass such as legs, buttocks, back, or shoulders can generate a strong nonpainful intensity without concurrent muscle contractions because of higher motor thresholds in these regions.
The current window for 2 pps was larger than 30 pps and 80 pps, and higher amplitudes within the current window were used for strong nonpainful TENS at 2 pps compared with 30 pps and 80 pps. It is possible that measurement error contributed in part to this finding because longer interpulse intervals occur with 2 pps making it more likely to overshoot PTh as current amplitude increases. The investigator controlled the current amplitude dial on the TENS device to standardize the rate of increase of current amplitude. This may have increased anxiety in participants and the possibility of underestimating thresholds. We have no evidence that this was the case.
There are many studies using healthy human participants exposed to experimental pain to investigate the effect of TENS frequency, pattern, width, and waveform on hypoalgesia [13] [14] [15] [34] [35] [36] (for reviews see references 1,2,37). However, there are remarkably few experimental investigations on the role of electrode placement in outcome. To date, most studies have compared the effect of TENS at 2 body sites. For example, Chesterton et al 35 found that highfrequency and high-intensity segmental TENS produced rapid onset hypoalgesia to pressure algometry, whereas other combinations of TENS frequencies (110 or 4 Hz), intensities (strong but comfortable or highest tolerable), and sites (segmental or extrasegmental) were no different to placebo (no current) TENS. Cheing and Chan 17 found no differences in the change in mechanical PTh when TENS was administered over acupuncture points compared with peripheral nerve points, and Brown et al 18 found no differences in experimentally induced ischemic pain in the arm when TENS was given on the arm compared with the leg. It is possible that methodological shortcomings may have contributed to false negative findings in these studies. 37 Studies that investigate electrode placement on pain patients are even more rare. Rao et al 16 found no correlation between TENS electrode placement or stimulating param-eters on pain relief in 114 chronic pain patients. Johnson et al 38 found that successful long-term users of TENS place electrodes to generate strong nonpainful electrical paresthesiae in the site of their chronic pain.
The effectiveness of TENS in clinical practice remains controversial due to methodological shortcomings in randomized controlled clinical trials. Recently, we have demonstrated that low fidelity may explain negative findings in randomized controlled trials of TENS for pain with under dosing and inadequate TENS technique being a recurring problem. 39 There has been much research into the electrical characteristics of TENS to maximize analgesic efficacy but a lack of good quality preclinical, modeling and exploratory phases of development from the users' perspective to establish adequate technique with respect to comfortable stimulation at different body sites.
In conclusion, our findings show that TENS is most comfortable and easiest to titrate to a strong nonpainful intensity when applied over areas of muscle and soft tissue. In some instances TENS can be uncomfortable even when administered at intensities below PTh. This could reduce the patient's confidence in and acceptance of TENS as a potentially useful treatment.
